Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

46
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
46
Antibiotic Selection00:57

Antibiotic Selection

62.1K
Overview
62.1K
Production of Antibiotics01:27

Production of Antibiotics

63
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
63
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

58
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
58
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

879
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
879
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.

Brain : a journal of neurology·2026
Same author

Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU.

Frontiers in medicine·2026
Same author

Proteomic profiling of whole tissue sections in cardiac ATTR amyloidosis reveals increased extracellular matrix remodeling.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same author

A Platform for High-throughput and Ultrasensitive Immunopeptidomics.

Molecular & cellular proteomics : MCP·2026
Same author

Confirmation of monotypic immunofluorescence staining by mass spectrometry in a case of proliferative glomerulonephritis.

Histopathology·2026
Same author

A roadmap for supporting the development of advanced therapy medicinal products in a European framework.

The Lancet regional health. Europe·2026

Related Experiment Video

Updated: Mar 30, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.8K

Protein aggregation as an antibiotic design strategy.

Natalia G Bednarska1,2, Johan van Eldere1, Rodrigo Gallardo2,3

  • 1Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology and Immunology, KULeuven, Leuven, Belgium.

Molecular Microbiology
|November 13, 2015
PubMed
Summary

Researchers developed novel antimicrobial peptides that target bacterial protein aggregation, offering a new strategy against infections like methicillin-resistant Staphylococcus aureus. These peptides show promise for treating sepsis with minimal host toxicity.

More Related Videos

Extraction and Visualization of Protein Aggregates after Treatment of Escherichia coli with a Proteotoxic Stressor
07:59

Extraction and Visualization of Protein Aggregates after Treatment of Escherichia coli with a Proteotoxic Stressor

Published on: June 29, 2021

4.3K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K

Related Experiment Videos

Last Updated: Mar 30, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.8K
Extraction and Visualization of Protein Aggregates after Treatment of Escherichia coli with a Proteotoxic Stressor
07:59

Extraction and Visualization of Protein Aggregates after Treatment of Escherichia coli with a Proteotoxic Stressor

Published on: June 29, 2021

4.3K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Bacterial infections pose a significant threat, necessitating novel therapeutic strategies.
  • Targeting pathogen-specific mechanisms, like protein aggregation, offers a potential avenue for selective antimicrobial action.
  • Exploiting the xenobiotic nature of bacteria is key to developing treatments that spare host cells.

Purpose of the Study:

  • To investigate the potential of using aggregation-prone peptide sequences from bacterial proteomes to induce toxic protein aggregation specifically within bacterial pathogens.
  • To assess the antimicrobial activity and host safety of these identified peptides.
  • To explore a new chemical space for developing novel antimicrobial therapies.

Main Methods:

  • In vitro screening of bacterial genome-derived peptide sequences for aggregation propensity and bactericidal activity.
  • In vivo testing of identified peptides in a mouse model of bacterial sepsis.
  • Histological and hematological evaluations to assess in vivo toxicity.
  • Microscopic analysis to determine peptide localization and mechanism of action within bacterial cells.

Main Results:

  • Identification of several peptides exhibiting strong bactericidal activity against methicillin-resistant Staphylococcus aureus (MRSA).
  • Successful treatment of bacterial sepsis in mice upon parenteral administration of these peptides.
  • Absence of apparent toxic side effects in treated mice, confirmed by histological and hematological analyses.
  • Demonstration that peptides enter and accumulate in the bacterial cytosol, inducing bacterial polypeptide aggregation.

Conclusions:

  • Peptides derived from aggregation-prone bacterial protein sequences can selectively induce toxic protein aggregation in bacteria, leading to cell death.
  • This approach represents a promising, unexplored strategy for developing novel antimicrobial agents against challenging bacterial pathogens.
  • The identified peptides demonstrate therapeutic potential for treating bacterial infections, including sepsis, with a favorable safety profile.